TLDR Tech / Launches
OpenAI Offers Rosalind Academic Plan for Drug Discovery Labs
OpenAI has launched the Rosalind Academic Plan, granting academic labs and principal investigators at eligible institutions access to GPT-Rosalind for drug and protein design. Researchers can apply directly if they lack an existing Enterprise account, or request access through their current OpenAI Enterprise agreements.
Read the full story